DK3476395T3 - Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme - Google Patents
Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme Download PDFInfo
- Publication number
- DK3476395T3 DK3476395T3 DK18758465.1T DK18758465T DK3476395T3 DK 3476395 T3 DK3476395 T3 DK 3476395T3 DK 18758465 T DK18758465 T DK 18758465T DK 3476395 T3 DK3476395 T3 DK 3476395T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- composition including
- heart diseases
- including fibroblasts
- injectible composition
- Prior art date
Links
- 210000002950 fibroblast Anatomy 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017033624 | 2017-02-24 | ||
| PCT/JP2018/006795 WO2018155651A1 (ja) | 2017-02-24 | 2018-02-23 | 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3476395T3 true DK3476395T3 (da) | 2021-08-16 |
Family
ID=63253929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18758465.1T DK3476395T3 (da) | 2017-02-24 | 2018-02-23 | Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11096969B2 (da) |
| EP (1) | EP3476395B1 (da) |
| JP (2) | JP6618066B2 (da) |
| KR (1) | KR102407387B1 (da) |
| CN (1) | CN109890398B (da) |
| AU (1) | AU2018223739B2 (da) |
| CA (1) | CA3032654A1 (da) |
| DK (1) | DK3476395T3 (da) |
| ES (1) | ES2885080T3 (da) |
| IL (1) | IL267958B2 (da) |
| SG (1) | SG11201900810WA (da) |
| WO (1) | WO2018155651A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3110831A1 (en) * | 2018-08-29 | 2020-03-05 | Metcela Inc. | Method for producing fibroblast, and g-csf-positive fibroblast mass |
| CN109589337B (zh) * | 2018-12-29 | 2022-04-26 | 南京艾尔普再生医学科技有限公司 | 心肌细胞制剂及其制备方法和应用 |
| CN115210361B (zh) * | 2020-03-04 | 2024-12-10 | 淋巴奥格尼克斯有限公司 | 促红细胞生成素产生能力增强的成纤维细胞、制造方法以及医药组合物 |
| CA3211113A1 (en) * | 2021-03-04 | 2022-09-09 | Metcela Inc. | Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same |
| JPWO2023037868A1 (da) * | 2021-09-08 | 2023-03-16 | ||
| EP4249585A1 (en) * | 2022-03-25 | 2023-09-27 | Technische Universität München - TUM | Heart tissue models, method of producing heart tissue models and uses of heart tissue models |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| WO2003095016A1 (en) * | 2002-05-08 | 2003-11-20 | The Regents Of The University Of California | System and method for forming a non-ablative cardiac conduction block |
| CA2487254A1 (en) * | 2002-05-08 | 2003-11-20 | The Regents Of The University Of California | System and method for treating cardiac arrhythmias with fibroblast cells |
| US20040161412A1 (en) * | 2002-08-22 | 2004-08-19 | The Cleveland Clinic Foundation | Cell-based VEGF delivery |
| US7470538B2 (en) * | 2002-12-05 | 2008-12-30 | Case Western Reserve University | Cell-based therapies for ischemia |
| JP2007520259A (ja) * | 2003-11-10 | 2007-07-26 | シンフォニー メディカル， インコーポレイテッド | 心房細動患者における心室速度を制御するための方法 |
| US8513011B2 (en) * | 2004-08-26 | 2013-08-20 | Biotech Research Ventures Pte Limited | Methods and compositions for culturing cardiomyocyte-like cells |
| ES2325715B1 (es) * | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
| JP5378743B2 (ja) | 2008-09-30 | 2013-12-25 | テルモ株式会社 | 医療用細胞シートの製造方法 |
| WO2013028968A1 (en) * | 2011-08-25 | 2013-02-28 | Wisconsin Alumni Research Foundation | 3-dimensional cardiac fibroblast derived extracellular matrix |
| JP5920741B2 (ja) | 2012-03-15 | 2016-05-18 | ｉＨｅａｒｔ Ｊａｐａｎ株式会社 | 人工多能性幹細胞から心筋および血管系混合細胞群を製造する方法 |
| WO2014039995A1 (en) * | 2012-09-07 | 2014-03-13 | Fibrocell Technologies, Inc. | Fibroblast compositions for treating cardial damage after an infarct |
| GB201309057D0 (en) * | 2013-05-20 | 2013-07-03 | Cell Therapy Ltd | Method |
| KR20150009655A (ko) * | 2013-07-16 | 2015-01-27 | 학교법인 동아학숙 | Gcp-2 유전자를 과발현하는 지방 간엽줄기세포를 포함하는 허혈성 질환 치료용 조성물 |
| CA2954743C (en) | 2014-07-11 | 2022-03-15 | Metcela Inc. | Cardiac cell culture material |
-
2018
- 2018-02-23 KR KR1020197003364A patent/KR102407387B1/ko active Active
- 2018-02-23 CA CA3032654A patent/CA3032654A1/en active Pending
- 2018-02-23 AU AU2018223739A patent/AU2018223739B2/en active Active
- 2018-02-23 WO PCT/JP2018/006795 patent/WO2018155651A1/ja not_active Ceased
- 2018-02-23 CN CN201880003050.1A patent/CN109890398B/zh active Active
- 2018-02-23 ES ES18758465T patent/ES2885080T3/es active Active
- 2018-02-23 JP JP2019501845A patent/JP6618066B2/ja active Active
- 2018-02-23 EP EP18758465.1A patent/EP3476395B1/en active Active
- 2018-02-23 SG SG11201900810WA patent/SG11201900810WA/en unknown
- 2018-02-23 DK DK18758465.1T patent/DK3476395T3/da active
-
2019
- 2019-01-31 US US16/263,321 patent/US11096969B2/en active Active
- 2019-07-09 IL IL267958A patent/IL267958B2/en unknown
- 2019-10-03 JP JP2019182761A patent/JP7072135B2/ja active Active
-
2021
- 2021-07-19 US US17/379,671 patent/US20210346436A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018155651A1 (ja) | 2018-08-30 |
| EP3476395A4 (en) | 2020-02-26 |
| AU2018223739B2 (en) | 2023-06-22 |
| JP2019218408A (ja) | 2019-12-26 |
| CN109890398B (zh) | 2024-01-16 |
| EP3476395B1 (en) | 2021-07-21 |
| CN109890398A (zh) | 2019-06-14 |
| IL267958A (en) | 2019-09-26 |
| CA3032654A1 (en) | 2018-08-30 |
| JPWO2018155651A1 (ja) | 2019-11-07 |
| IL267958B1 (en) | 2023-04-01 |
| JP7072135B2 (ja) | 2022-05-20 |
| US20210346436A1 (en) | 2021-11-11 |
| EP3476395A1 (en) | 2019-05-01 |
| US20190224250A1 (en) | 2019-07-25 |
| SG11201900810WA (en) | 2019-02-27 |
| JP6618066B2 (ja) | 2019-12-11 |
| IL267958B2 (en) | 2023-08-01 |
| KR102407387B1 (ko) | 2022-06-10 |
| ES2885080T3 (es) | 2021-12-13 |
| KR20190117468A (ko) | 2019-10-16 |
| AU2018223739A1 (en) | 2019-02-14 |
| US11096969B2 (en) | 2021-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3359171C0 (en) | Use of akkermansia muciniphila for treating inflammatory conditions | |
| EP3383411C0 (en) | SUB-MITOCHONDRIAL PARTICLES FOR USE IN THE TREATMENT OF METABOLIC DISEASES | |
| EP3263132C0 (en) | COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IL-6 | |
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| EP3402486C0 (en) | CCX168 FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHY | |
| EP3515420C0 (en) | PHARMACEUTICAL COMPOSITIONS FOR USE IN BLEPHARITIS THERAPY | |
| IL256166B (en) | Compounds for use in treating neuromuscular disorders | |
| DK3476395T3 (da) | Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme | |
| EP3349783C0 (en) | COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES | |
| DK3377637T3 (da) | Sammensætninger til anvendelse i fremgangsmåder til behandling af sår, lidelser og sygdomme i huden | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| SI3346995T1 (sl) | Terapevtski sestavek za zdravljenje virusa človeške imunske pomanjkljivosti | |
| PL3381451T3 (pl) | Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej | |
| DK2945642T3 (da) | Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme | |
| DK3806898T3 (da) | Gremlin-1-antagonist til anvendelse i behandling af cancer | |
| ZA201902275B (en) | Topical dressing composition for the treatment of damaged skin tissue | |
| DK3710000T3 (da) | Tradipitant til anvendelse til behandling af gastroparese | |
| EP3496733C0 (en) | COMPOSITION FOR USE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER | |
| IL270978B (en) | Grape skin for use in the treatment of dysbiosis | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| EP3773539A4 (en) | COMPOSITIONS FOR THE TREATMENT OF THE SKIN | |
| EP3395341C0 (en) | COMPOSITION FOR THE TREATMENT OF NEUROMOTOR DISEASES AND ITS USE | |
| DK3761982T3 (da) | Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii |